You are viewing the public part of the archive. Login or request access to view more content.
Displaying 1-7 of 7 results
00:11:44
2012_94
XIX International AIDS Conference in Washington D.C. Barton Haynes from the Duke Human Vaccine Institute (DHVI) has been working in the HIV vaccine field since 1985. Here he talks about the scientific difficulties of finding an HIV vaccine.
2012_94
00:05:56
2012_39
XIX International AIDS Conference. Interview with Shomyseh Sanjabi who is a basic Immunlogist at Gladstone Institutes. She tells about their animal model studies of HIV transmission and ageing with HIV. She is part of the CNIHR program.
2012_39
00:03:37
2012_37
XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.
2012_37
00:03:57
2012_36
XIX International AIDS Conference. Gretchen Neigh is a neurologist at Emory University in Atlanta working with basic research on depression. She tells about her current work on depression in HIV positive rats and her future hopes for research in humans.
2012_36
00:23:50
America and AIDS
This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.
2007_america_and_aids_edited
00:16:08
2006_4_03
In the last part of the interview with Dr Anthony Fauci he reflects on the global HIV/AIDS situation and response. He also compares AIDS to other diseases such as the Bird Flu, and discusses the specific social and socioeconomic factors of HIV/AIDS.
2006_4_03
00:12:05
1994_40
Anthony Fauci is interviewed about the progression from HIV to AIDS. He talks about HIV long-term survivors and different aspects of non-progression to AIDS. He also reflects on the future for antiretroviral drugs and HIV vaccines.
1994_40